Ilika
IKA · AIM · Industrial Goods and Services · mcap £41m · 20.5p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 16 Sep 26 | Appointment of Defence Advisor to Ilika
Ilika appoints Maj Gen (Retd) Robin Anderton-Brown as strategic defence sector advisor. |
+0.0% | |
| 10 Sep 26 | Goliath Prototyping Progress
Ilika completes PRIMED programme optimising Goliath 10Ah solid-state battery prototypes with improved performance metrics. |
+4.3% | |
| 29 Jul 26 | Results | Final Results
Full year results show Stereax batteries transitioned to revenue-generating commercial business; Goliath validation progressing. |
−8.8% |
| 07 Jul 26 | Fundraise | Result of Retail Offer
Retail offer oversubscribed; raised £0.5m at 28p per share, completing £5.0m capital raise. |
+0.0% |
| 03 Jul 26 | Offer | Retail Offer for up to £0.5 million
Ilika launches retail offer for up to £0.5m at 28p per share to fund product development. |
−2.8% |
| 03 Jul 26 | Fundraise | Result of Placing & Director Subscription
Raised £4.56m gross from oversubscribed placing at 28p per share; further £0.5m retail offer planned. |
−2.8% |
| 02 Jul 26 | Proposed Capital Raising to raise £5.0 million
Ilika proposes placing 16m shares at 28p to raise £4.5m, plus retail offer and director subscriptions targeting £5.0m total. |
+0.0% | |
| 21 May 26 | Ilika Trading Update and Notice of Results
Ilika (AIM: IKA), the UK pioneer in solid-state battery technology, provides an update on trading as well as issuing its notice of full year results for the year ended 30 April 2026. |
+0.0% | |
| 10 Apr 26 | Collaboration with Brompton Bicycles
Ilika to collaborate with Brompton Bicycles on 12-month joint development programme to integrate Goliath battery technology into e-bikes. |
−3.7% | |
| 18 Mar 26 | Positive Feedback on Safety of Goliath Cells
UK Defence agency confirms Goliath cells survive battlefield safety tests, expressing interest in further evaluation. |
+2.2% | |
| 10 Mar 26 | First Commercial Delivery to Cirtec Medical
Ilika completes first commercial electrode delivery to Cirtec Medical for Stereax M300 battery production. |
+1.7% | |
| 24 Feb 26 | Award of Share Options
Executive Directors and employees granted share options totalling 2.69m shares under LTIP and EMI schemes. |
−1.8% | |
| 19 Feb 26 | Replacement
CEO and CFO to present at Yellowstone Advisory private investor evening on 25 February 2026. |
+0.0% | |
| 22 Jan 26 | Results | Half-year Results
Ilika achieved key milestones in Stereax medical battery production and Goliath EV battery validation during H1 FY2025/26. |
−2.6% |
| 21 Jan 26 | Ilika Secures Stereax Electrode Order from Cirtec
Ilika secures first revenue-generating order from Cirtec Medical for Stereax electrodes for medical devices. |
+4.1% | |
| 18 Dec 25 | Initial Stereax M300 Shipments
Ilika commences shipping prototype Stereax M300 solid state batteries to 21 customers from order book. |
+1.6% | |
| 11 Dec 25 | Ilika Ships 10Ah Goliath Battery Prototypes
Ilika begins shipping 10Ah Goliath battery prototypes to automotive and other customers. |
+2.4% | |
| 20 Nov 25 | Results | Trading Update & Notice of Half-Year Results
Ilika (AIM: IKA), the UK pioneer in solid-state battery technology, provides an update on trading for the six months ended 31 October 2025 (the "Period"). |
+1.2% |
| 21 Oct 25 | Commissioning Complete for Goliath Pilot Line
Goliath automated pilot line completed and operational, enabling customer prototype delivery from December 2025. |
+0.0% |
Company filings. Not investment advice.